Treatment-induced hypoxia attenuates Enzalutamide response and promotes resistance in pre-clinical models of prostate cancer

Pamela Maxwell; Melissa LaBonte Wilson; Melanie McKechnie; Chris Armstrong; Chee Wee Ong; Jenny Worthington; David Waugh

Treatment-induced hypoxia attenuates Enzalutamide response and promotes resistance in pre-clinical models of prostate cancer

Pamela Maxwell, Melissa LaBonte Wilson, Melanie McKechnie, Chris Armstrong, Chee Wee Ong, Jenny Worthington, David Waugh

Research output: Contribution to conference › Poster › peer-review

Original language	English
Publication status	Published - 2017
Event	European Alliance for Personalised Medicine Conference : “Personalising your Health: A Global Imperative” - Belfast, United Kingdom Duration: 25 Nov 2017 → 29 Nov 2017

Conference

Conference	European Alliance for Personalised Medicine Conference
Country/Territory	United Kingdom
City	Belfast
Period	25/11/2017 → 29/11/2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{72a43428f3534a8fa1995ef026d3cd64,

title = "Treatment-induced hypoxia attenuates Enzalutamide response and promotes resistance in pre-clinical models of prostate cancer",

author = "Pamela Maxwell and {LaBonte Wilson}, Melissa and Melanie McKechnie and Chris Armstrong and Ong, {Chee Wee} and Jenny Worthington and David Waugh",

year = "2017",

language = "English",

note = "European Alliance for Personalised Medicine Conference : “Personalising your Health: A Global Imperative” ; Conference date: 25-11-2017 Through 29-11-2017",

}

Treatment-induced hypoxia attenuates Enzalutamide response and promotes resistance in pre-clinical models of prostate cancer. / Maxwell, Pamela ; LaBonte Wilson, Melissa; McKechnie, Melanie et al.

2017. Poster session presented at European Alliance for Personalised Medicine Conference , Belfast, United Kingdom.

Research output: Contribution to conference › Poster › peer-review

TY - CONF

T1 - Treatment-induced hypoxia attenuates Enzalutamide response and promotes resistance in pre-clinical models of prostate cancer

AU - Maxwell, Pamela

AU - LaBonte Wilson, Melissa

AU - McKechnie, Melanie

AU - Armstrong, Chris

AU - Ong, Chee Wee

AU - Worthington, Jenny

AU - Waugh, David

PY - 2017

Y1 - 2017

M3 - Poster

T2 - European Alliance for Personalised Medicine Conference

Y2 - 25 November 2017 through 29 November 2017

ER -